[1]张于芝,丁文波,武心萍,等.细针穿刺洗脱液甲状旁腺激素测定诊断原发性甲状旁腺功能亢进病灶的临床研究[J].国际内分泌代谢杂志,2024,44(01):14-18.[doi:10.3760/cma.j.cn121383-20221231-12054]
　Zhang Yuzhi,Ding Wenbo,Wu Xinping,et al.Clinical study on the diagnosis of primary hyperparathyroidism lesions with parathyroid hormone assay in fine needle aspiration washout[J].International Journal of Endocrinology and Metabolism,2024,44(01):14-18.[doi:10.3760/cma.j.cn121383-20221231-12054]
点击复制

细针穿刺洗脱液甲状旁腺激素测定诊断原发性甲状旁腺功能亢进病灶的临床研究()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
44
期数:
2024年01期
页码:
14-18
栏目:
论著
出版日期:
2024-01-20

文章信息/Info

Title:
Clinical study on the diagnosis of primary hyperparathyroidism lesions with parathyroid hormone assay in fine needle aspiration washout
作者:
张于芝1; 丁文波1; 武心萍1; 徐书杭2; 刘超2
1南京中医药大学附属中西医结合医院超声科,南京 210028; 2南京中医药大学附属中西医结合医院内分泌科,南京 210028
Author(s):
Zhang Yuzhi1;  Ding Wenbo1;  Wu Xinping1;  Xu Shuhang2;  Liu Chao2
1Department of Ultrasound, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China; 2Endocrine and Diabetes Center, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China
关键词:
原发性甲状旁腺功能亢进症;  甲状旁腺激素;  细针穿刺;  洗脱液;  超声
Keywords:
Primary hyperparathyroidism;  Parathyroid hormone;  Fine needle aspiration;  Washout;  Ultrasound
DOI:
10.3760/cma.j.cn121383-20221231-12054
摘要:
目的 探讨细针穿刺(FNA)洗脱液甲状旁腺激素(PTH)测定(FNA-PTH)对原发性甲状旁腺功能亢进病灶(HPTL)的诊断价值。方法 选择2018年10月至2023年2月经颈部超声检出可疑甲状旁腺病变的患者,结合血PTH、核素显像、术后病理结果判定HPTL,分析FNA-PTH对HPTL的诊断效能,并构建合理的诊断切点。结果 本研究共纳入94例患者、98个结节,其中76例患者(80个结节)接受了FNA检查。HPTL与非HPTL的FNA-PTH中位数分别为2 396.50 pg/ml(Q1～Q3:878.08～5 000.00 pg/ml)、21.98 pg/ml(16.04～32.16 pg/ml),FNA-PTH/血清PTH比值(PTH比值)中位数分别为12.47(4.89～29.43)、0.62(0.45～0.79),差异均有统计学意义(P值均<0.001)。ROC曲线显示FNA-PTH测值的AUC略高于PTH比值(0.937 比 0.849)。以187.90 pg/ml作为FNA-PTH的诊断界值时敏感性为88.9%,特异性与准确性均为90.9%,与PTH比值无统计学差异(P=1.0)。结论 FNA-PTH检测对HPTL具有很高的定位与诊断价值,以187.90 pg/ml作为诊断切点效能最佳。
Abstract:
Objective To investigate the diagnostic value of parathyroid hormone measurement in fine needle aspiration washout(FNA-PTH)in primary hyperparathyroidism lesions(HPTLs).Methods Patients with suspected parathyroid lesions detected by neck ultrasonography from October 2018 to February 2023 were selected, and HPTL was determined based on serum parathyroid hormone(PTH), radionuclide imaging, and postoperative pathological results. The diagnostic value of FNA-PTH on HPTL was analyzed, and an effective diagnostic cut-off point was also established.Results A total of 94 patients and 98 nodules were enrolled in this study, of which 76 patients(80 nodules)underwent FNA. The median values of FNA-PTH for HPTLs and non-HPTLs were 2 396.50 pg/ml(878.08-5 000.00 pg/ml), 21.98 pg/ml(16.04-32.16 pg/ml), and FNA-PTH/serum PTH(PTH ratio)were 12.47(4.89-29.43)and 0.62(0.45-0.79), respectively; the differences were statistically significant(all P<0.001). The ROC curve showed that the AUC of the FNA-PTH value was slightly higher than the PTH ratio(0.937 vs 0.849). Taking 187.90 pg/ml as the diagnostic cut-off value, the sensitivity, specificity, and accuracy of FNA-PTH were 88.9%, 90.9%, and 90.0%, respectively. The efficacy was slightly better than the PTH ratio without statistical difference.Conclusions FNA-PTH testing is of great value in the localization and diagnosis of HPTL, with 187.90pg/ml as the optimal diagnostic cut-off.

参考文献/References:

[1] 中华医学会骨质疏松和骨矿盐疾病分会,中华医学会内分泌分会代谢性骨病学组.原发性甲状旁腺功能亢进症诊疗指南[J].中华骨质疏松和骨矿盐疾病杂志,2014,7(3):187-198.DOI:10.3969/j.issn.1674-2591.2014.03.002.
[2] Bilezikian JP,Khan AA,Silverberg SJ,et al.Evaluation and management of primary hyperparathyroidism:summary statement and guidelines from the Fifth International Workshop[J].J Bone Miner Res,2022,37(11):2293-2314.DOI:10.1002/jbmr.4677.
[3] Oboończyk ,Karwacka I,Wis'niewski P,et al.The current role of parathyroid fine-needle biopsy(P-FNAB)with iPTH-washout concentration(iPTH-WC)in primary hyperparathyroidism:a single center experience and literature review[J].Biomedicines,2022,10(1):123.DOI:10.3390/biomedicines10010123.
[4] Castellana M,Virili C,Palermo A,et al.Primary hyperparathyroidism with surgical indication and negative or equivocal scintigraphy:safety and reliability of PTH washout.a systematic review and meta-analysis[J].Eur J Endocrinol,2019,181(3):245-253.DOI:10.1530/EJE-19-0160.
[5] Gökçay Canpolat A, �瘙 塁 ahin M,Edibogˇlu E,et al.Diagnostic accuracy of parathyroid hormone levels in washout samples of suspicious parathyroid adenomas:a single-centre retrospective cohort study[J].Clin Endocrinol(Oxf),2018,89(4):489-495.DOI:10.1111/cen.13812.
[6] Guilmette J,Sadow PM.Parathyroid pathology[J].Surg Pathol Clin,2019,12(4):1007-1019.DOI:10.1016/j.path.2019.08.006.
[7] Sung JY.Parathyroid ultrasonography:the evolving role of the radiologist[J].Ultrasonography,2015,34(4):268-274.DOI:10.14366/usg.14071.
[8] Cheung K,Wang TS,Farrokhyar F,et al.A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism[J].Ann Surg Oncol,2012,19(2):577-583.DOI:10.1245/s10434-011-1870-5.
[9] Ippolito G,Palazzo FF,Sebag F,et al.A single-institution 25-year review of true parathyroid cysts[J].Langenbecks Arch Surg, 2006,391(1):13-8.DOI:10.1007/s00423-005-0579-y.
[10] Hu Y,Cui M,Xia Y,et al.The clinical features of cystic parathyroid adenoma in Chinese population:a single-center experience[J].Int J Endocrinol,2018,2018:3745239.DOI:10.1155/2018/3745239.
[11] Vitetta GM,Ravera A,Mensa G,et al.Actual role of color-doppler high-resolution neck ultrasonography in primary hyperparathyroidism:a clinical review and an observational study with a comparison of 99mTc-sestamibi parathyroid scintigraphy[J].J Ultrasound,2019,22(3):291-308.DOI:10.1007/s40477-018-0332-3.
[12] Agarwal C,Kaushal M.Parathyroid lesions:difficult diagnosis on cytology[J].Diagn Cytopathol,2016,44(8):704-709.DOI:10.1002/dc.23508.
[13] Marcocci C,Mazzeo S,Bruno-Bossio G,et al.Preoperative localization of suspicious parathyroid adenomas by assay of parathyroid hormone in needle aspirates[J].Eur J Endocrinol,1998,139(1):72-77.DOI:10.1530/eje.0.1390072.
[14] Ketha H,Lasho MA,Algeciras-Schimnich A.Analytical and clinical validation of parathyroid hormone(PTH)measurement in fine-needle aspiration biopsy(FNAB)washings[J].Clin Biochem,2016,49(1-2):16-21.DOI:10.1016/j.clinbiochem.2015.09.006.
[15] Maser C,Donovan P,Santos F,et al.Sonographically guided fine needle aspiration with rapid parathyroid hormone assay[J].Ann Surg Oncol,2006,13(12):1690-1695.DOI:10.1245/s10434-006-9180-z.
[16] Machado NN,Wilhelm SM.Diagnosis and evaluation of primary hyperparathyroidism[J].Surg Clin North Am,2019,99(4):649-666.DOI:10.1016/j.suc.2019.04.006.
[17] Khanna S,Singh S,Khanna AK.Parathyroid incidentaloma[J].Indian J Surg Oncol,2012,3(1):26-29.DOI:10.1007/s13193-012-0143-5.

相似文献/References:

[1]高飞,董旋,徐倩倩,等.AGEs对大鼠骨髓间充质干细胞成骨分化中β-catenin、ALP的影响及PTH的干预作用[J].国际内分泌代谢杂志,2021,41(03):173.[doi:10.3760/cma.j.cn121383-20210225-02059]
　Gao Fei,Dong Xuan,Xu Qianqian,et al.Effects of AGEs on β-catenin and ALP in osteogenic differentiation of rat bone marrow mesenchymal stem cells and the intervention of PTH[J].International Journal of Endocrinology and Metabolism,2021,41(01):173.[doi:10.3760/cma.j.cn121383-20210225-02059]
[2]杨帆,李平,朱大龙.原发性甲状旁腺功能亢进症诊治中的焦点问题[J].国际内分泌代谢杂志,2021,41(06):553.[doi:10.3760/cma.j.cn121383-20210924-09072]
　Yang Fan,Li Ping,Zhu Dalong..Focal points in the diagnosis and treatment of primary hyperparathyroidism[J].International Journal of Endocrinology and Metabolism,2021,41(01):553.[doi:10.3760/cma.j.cn121383-20210924-09072]
[3]倪文婧 徐书杭 王建华 刘超.超声引导下热消融治疗原发性甲状旁腺功能亢进症的现状和展望[J].国际内分泌代谢杂志,2022,42(04):268.[doi:10.3760/cma.j.cn121383-20201223-12075]
　Ni Wenjing,Xu Shuhang,Wang Jianhua,et al.Current status and prospects of ultrasound-guided thermal ablation in the treatment of primary hyperparathyroidism[J].International Journal of Endocrinology and Metabolism,2022,42(01):268.[doi:10.3760/cma.j.cn121383-20201223-12075]

备注/Memo

备注/Memo:
基金项目:2020年江苏省重点研发计划(BE2020726); 中华国际医学交流基金会甲状腺中青年医生研究项目(BQE-JZX-202115); 江苏省卫生健康委 2020 年度医学科研项目(M2020102)
通信作者:徐书杭,Email:shuhangxu@163.com
更新日期/Last Update: 2024-03-20